Omeros Corporation Initiates its Phase 3 Program for OMS721 in aHUS Following Meeting with FDA
Go back to Omeros Corporation Initiates its Phase 3 Program for OMS721 in aHUS Following Meeting with FDA| Omeros Corporation (NASDAQ: OMER) | Delayed: 10.48 +0.15 (1.45%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.33 | 52 Week High | $16.80 | |||
| Open | $10.28 | 52 Week Low | $7.20 | |||
| Day High | $10.60 | P/E | N/A | |||
| Day Low | $10.10 | EPS | $-1.64 | |||
| Volume | 1,073,153 | |||||
